UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic Value of Plasma Fibrinolysis Activation Markers in Cardiovascular Disease

Journal of the American College of Cardiology, 2010-06, Vol.55 (24), p.2701-2709

Gorog, Diana A., MD, PhD

2010

Volltextzugriff (PDF)

Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19

European heart journal, 2020-09, Vol.41 (33), p.3198-3199

2020

Volltextzugriff (PDF)

Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium

Nature reviews cardiology, 2022-07, Vol.19 (7), p.475-495

2022

Volltextzugriff (PDF)

Allopurinol as a therapeutic option in cardiovascular disease

Pharmacology & therapeutics (Oxford), 2017-04, Vol.172, p.139-150

2017

Volltextzugriff (PDF)

Endogenous Fibrinolysis

Journal of the American College of Cardiology, 2015-04, Vol.65 (16), p.1683-1699

2015

Volltextzugriff (PDF)

Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19

Scientific reports, 2020-12, Vol.10 (1), p.21379-21379, Article 21379

2020

Volltextzugriff (PDF)

Fibrinolysis in Platelet Thrombi

International journal of molecular sciences, 2021-05, Vol.22 (10), p.5135

2021

Volltextzugriff (PDF)

Point-of-care tests of platelet reactivity and clot strength in risk assessment post-PCI: more insight into what really matters

European heart journal, 2024-07, Vol.45 (25), p.2232-2234

Gorog, Diana A

2024

Volltextzugriff (PDF)

Usefulness of the NULL-PLEASE Score to Predict Survival in Out-of-Hospital Cardiac Arrest

The American journal of medicine, 2020-11, Vol.133 (11), p.1328-1335

2020

Volltextzugriff (PDF)

Role, Laboratory Assessment and Clinical Relevance of Fibrin, Factor XIII and Endogenous Fibrinolysis in Arterial and Venous Thrombosis

International journal of molecular sciences, 2021-02, Vol.22 (3), p.1472

2021

Volltextzugriff (PDF)

Platelet Function Testing: A Role for Personalised Therapy in Coronary Disease

Current pharmaceutical design, 2017-01, Vol.23 (9), p.1315-1327

2017

Volltextzugriff (PDF)

Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation

International journal of molecular sciences, 2017-08, Vol.18 (9), p.1850

2017

Volltextzugriff (PDF)

Author Correction: Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19

Scientific reports, 2021-04, Vol.11 (1), p.8011-8011, Article 8011

2021

Volltextzugriff (PDF)

Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: a Pandora Box to Explain Prognostic Differences

Korean Circulation Journal, 2021, 51(3), , pp.202-221

2021

Volltextzugriff (PDF)

Global Thrombosis Test: Occlusion Is Attributable to Shear-Induced Platelet Thrombus Formation

TH open : companion journal to thrombosis and haemostasis, 2021-10, Vol.5 (4), p.e591-e597

2021

Volltextzugriff (PDF)

Global Thrombosis Test: Occlusion Is Attributable to Shear-Induced Platelet Thrombus Formation

TH open : companion journal to thrombosis and haemostasis, 2021-10, Vol.5 (4), p.e591-e597

2021

Volltextzugriff (PDF)

Use of thrombectomy devices in primary percutaneous coronary intervention: A systematic review and meta-analysis

International journal of cardiology, 2013-03, Vol.163 (3), p.229-241

2013

Volltextzugriff (PDF)

Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention

International journal of cardiology, 2021-08, Vol.337, p.1-8

2021

Volltextzugriff (PDF)

Impaired Endogenous Thrombolysis in Acute Coronary Syndrome Patients Predicts Cardiovascular Death and Nonfatal Myocardial Infarction

Journal of the American College of Cardiology, 2010-05, Vol.55 (19), p.2107-2115

2010

Volltextzugriff (PDF)

Tissue Factor Pathway Inhibitor and Interleukin-1 Receptor Levels in COVID-19

Thrombosis and haemostasis, 2024-08, Vol.124 (8), p.721-724

2024

Volltextzugriff (PDF)

Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease

European heart journal, 2013-02, Vol.34 (5), p.354-363

2013

Volltextzugriff (PDF)

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome

Journal of clinical medicine, 2020-06, Vol.9 (7), p.2020

2020

Volltextzugriff (PDF)

Measuring Thrombus Stability at High Shear, Together With Thrombus Formation and Endogenous Fibrinolysis: First Experience Using the Global Thrombosis Test 3 (GTT-3)

Clinical and applied thrombosis/hemostasis, 2023-01, Vol.29, p.10760296231181917-10760296231181917

2023

Volltextzugriff (PDF)

Platelet Inhibition in Acute Coronary Syndrome and Percutaneous Coronary Intervention: Insights from the Past and Present

Thrombosis and haemostasis, 2020-04, Vol.120 (4), p.565-578

2020

Volltextzugriff (PDF)

1 – 25 von 267

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(250)
Mit Volltextzugriff
(223)

Publikationsform

Sprache

Englisch
(267)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(157)
Life Sciences & Biomedicine
(151)
Cardiovascular System & Cardiology
(126)
Cardiac & Cardiovascular Systems
(103)
Humans
(100)
Thrombosis
(71)
Cardiology
(41)
Peripheral Vascular Disease
(38)
Male
(36)
Hematology
(32)
Female
(29)
Treatment Outcome
(29)
Myocardial Infarction
(28)
Acute Coronary Syndrome
(26)
Fibrinolysis
(26)
Middle Aged
(26)
Aged
(25)
Acute Coronary Syndromes
(24)
Heart Attacks
(24)
Blood Clots
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Prognostic Value of Plasma Fibrinolysis Activation Markers in Cardiovascular Disease

Reduction in ACE2 may mediate the prothrombotic phenotype in COVID-19

Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium

Allopurinol as a therapeutic option in cardiovascular disease

Endogenous Fibrinolysis

Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19

Fibrinolysis in Platelet Thrombi

Point-of-care tests of platelet reactivity and clot strength in risk assessment post-PCI: more insight into what really matters

Usefulness of the NULL-PLEASE Score to Predict Survival in Out-of-Hospital Cardiac Arrest

Role, Laboratory Assessment and Clinical Relevance of Fibrin, Factor XIII and Endogenous Fibrinolysis in Arterial and Venous Thrombosis

Platelet Function Testing: A Role for Personalised Therapy in Coronary Disease

Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation

Author Correction: Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19

Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study

Ethnic Difference of Thrombogenicity in Patients with Cardiovascular Disease: a Pandora Box to Explain Prognostic Differences

Global Thrombosis Test: Occlusion Is Attributable to Shear-Induced Platelet Thrombus Formation

Global Thrombosis Test: Occlusion Is Attributable to Shear-Induced Platelet Thrombus Formation

Use of thrombectomy devices in primary percutaneous coronary intervention: A systematic review and meta-analysis

Results of an international crowdsourcing survey on the treatment of non-ST segment elevation ACS patients at high-bleeding risk undergoing percutaneous intervention

Impaired Endogenous Thrombolysis in Acute Coronary Syndrome Patients Predicts Cardiovascular Death and Nonfatal Myocardial Infarction

Tissue Factor Pathway Inhibitor and Interleukin-1 Receptor Levels in COVID-19

Impaired thrombolysis: a novel cardiovascular risk factor in end-stage renal disease

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome

Measuring Thrombus Stability at High Shear, Together With Thrombus Formation and Endogenous Fibrinolysis: First Experience Using the Global Thrombosis Test 3 (GTT-3)

Platelet Inhibition in Acute Coronary Syndrome and Percutaneous Coronary Intervention: Insights from the Past and Present

Suchergebnisse filtern